298 related articles for article (PubMed ID: 33239387)
1. Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans.
Simoes S; Neufeld JL; Triana-Baltzer G; Moughadam S; Chen EI; Kothiya M; Qureshi YH; Patel V; Honig LS; Kolb H; Small SA
Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239387
[TBL] [Abstract][Full Text] [Related]
2. The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease.
Qureshi YH; Berman DE; Marsh SE; Klein RL; Patel VM; Simoes S; Kannan S; Petsko GA; Stevens B; Small SA
Cell Rep; 2022 Jan; 38(3):110262. PubMed ID: 35045281
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease.
Lim B; Tsolaki M; Soosaipillai A; Brown M; Zilakaki M; Tagaraki F; Fotiou D; Koutsouraki E; Grosi E; Prassas I; Diamandis EP
Clin Chem Lab Med; 2019 Nov; 57(12):1875-1881. PubMed ID: 31415236
[TBL] [Abstract][Full Text] [Related]
4. Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.
Begcevic I; Brinc D; Brown M; Martinez-Morillo E; Goldhardt O; Grimmer T; Magdolen V; Batruch I; Diamandis EP
J Proteomics; 2018 Jun; 182():12-20. PubMed ID: 29684683
[TBL] [Abstract][Full Text] [Related]
5. The Alzheimer's gene SORL1 is a regulator of endosomal traffic and recycling in human neurons.
Mishra S; Knupp A; Szabo MP; Williams CA; Kinoshita C; Hailey DW; Wang Y; Andersen OM; Young JE
Cell Mol Life Sci; 2022 Feb; 79(3):162. PubMed ID: 35226190
[TBL] [Abstract][Full Text] [Related]
6. Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype.
Li JG; Blass BE; Praticò D
J Alzheimers Dis; 2023; 91(1):463-469. PubMed ID: 36442197
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
8. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's vulnerable brain region relies on a distinct retromer core dedicated to endosomal recycling.
Simoes S; Guo J; Buitrago L; Qureshi YH; Feng X; Kothiya M; Cortes E; Patel V; Kannan S; Kim YH; Chang KT; ; Hussaini SA; Moreno H; Di Paolo G; Andersen OM; Small SA
Cell Rep; 2021 Dec; 37(13):110182. PubMed ID: 34965419
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic enhancement of retromer rescues endosomal pathology induced by defects in the Alzheimer's gene SORL1.
Mishra S; Knupp A; Kinoshita C; Williams CA; Rose SE; Martinez R; Theofilas P; Young JE
Stem Cell Reports; 2023 Dec; 18(12):2434-2450. PubMed ID: 37949073
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.
Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M
J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253
[TBL] [Abstract][Full Text] [Related]
14. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H
BMC Neurol; 2009 Dec; 9():63. PubMed ID: 20028512
[TBL] [Abstract][Full Text] [Related]
15. Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.
Qureshi YH; Baez P; Reitz C
Mol Cell Biol; 2020 Sep; 40(19):. PubMed ID: 32690545
[TBL] [Abstract][Full Text] [Related]
16. Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein.
Young JE; Fong LK; Frankowski H; Petsko GA; Small SA; Goldstein LSB
Stem Cell Reports; 2018 Mar; 10(3):1046-1058. PubMed ID: 29503090
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment.
Park JE; Choi KY; Kim BC; Choi SM; Song MK; Lee JJ; Kim J; Song HC; Kim HW; Ha JM; Seo EH; Song WK; Park SG; Lee JS; Lee KH
Dement Geriatr Cogn Dis Extra; 2019; 9(1):100-113. PubMed ID: 31011328
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL
J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322
[TBL] [Abstract][Full Text] [Related]
20. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
Somers C; Struyfs H; Goossens J; Niemantsverdriet E; Luyckx J; De Roeck N; De Roeck E; De Vil B; Cras P; Martin JJ; De Deyn PP; Bjerke M; Engelborghs S
J Alzheimers Dis; 2016 Aug; 54(1):383-95. PubMed ID: 27567807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
